News

Press Releases

May 12, 2015

Inflection Biosciences to Present at BioEquity Europe 2015

Dublin, Ireland, May 12, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Apr 27, 2015

Inflection Biosciences to Present at BioTrinity 2015

Dublin, Ireland, April 27, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Mar 16, 2015

Inflection Biosciences Appoints John Lynch to its Board of Directors

Dublin, Ireland, March 16, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Mar 9, 2015

Inflection Biosciences Raises €725,000 in Second Financing Round

Dublin, Ireland, March 9, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Feb 9, 2015

Multiple Myeloma Research Foundation & Inflection Biosciences Collaborate on a New Cancer Treatment

Dublin, Ireland, February 9, 2015 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Dec 3, 2014

Inflection Biosciences Announces Pre-clinical Data to be Presented at the ASH 2014 Annual Meeting

Dublin, Ireland, December 3rd, 2014 – Inflection Biosciences Ltd, a private company developing novel targeted small molecule therapeutics...

Nov 3, 2014

Inflection Biosciences Named Start-up Company of the Year at the Pharma Industry Awards 2014

Dublin, Ireland, November 3, 2014 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Oct 30, 2014

Inflection Biosciences Announces Research Collaboration with Trinity College Dublin

Dublin, Ireland, October 30, 2014 Inflection Biosciences Ltd, a private company developing targeted small molecule treatments for cancer,...

Oct 1, 2014

Inflection Biosciences Shortlisted for The Pharma Industry Awards 2014

Dublin, Ireland, October 1, 2014 Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Sep 15, 2014

Inflection Biosciences to Present at Annual BioPharm America International Partnering Conference

Dublin, Ireland, September 15, 2014 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...